Interestingly, cancer treatment with anti-PD-1 or CTLA4-immune checkpoint blockade can cause a drug-induced sarcoidosis-like disease, further highlighting the link between aberrant T cell activation and sarcoidosis [13]. The gene discussed is CTLA4; the disease is sarcoidosis.